Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring

Vitiligo is a common acquired skin disorder caused by immune-mediated destruction of epidermal melanocytes. Systemic glucocorticoids (GCs) have been used to prevent the progression of active vitiligo, with 8.2–56.2% of patients insensitive to this therapy. Currently, there is a lack of biomarkers th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yue-Tong, Liu, Xiao-Yan, Sun, Hai-Dan, Xu, Ji-Yu, Sun, Jia-Meng, Liu, Wei, Chen, Tian, Liu, Jia-Wei, Tan, Yan, Sun, Wei, Ma, Dong-Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891126/
https://www.ncbi.nlm.nih.gov/pubmed/35252347
http://dx.doi.org/10.3389/fmolb.2022.761562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891126/
https://www.ncbi.nlm.nih.gov/pubmed/35252347
http://dx.doi.org/10.3389/fmolb.2022.761562

Ejemplares similares